Wells Fargo’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Sell |
|
|||||
|
2025
Q1 | $175K | Sell |
|
|||||
|
2024
Q4 | $237K | Sell |
|
|||||
|
2024
Q3 | $1.72M | Buy |
|
|||||
|
2024
Q2 | $854K | Buy |
|
|||||
|
2024
Q1 | $956K | Buy |
|
|||||
|
2023
Q4 | $1.18M | Sell |
|
|||||
|
2023
Q3 | $1.64M | Sell |
|
|||||
|
2023
Q2 | $1.78M | Buy |
|
|||||
|
2023
Q1 | $1.56M | Sell |
|
|||||
|
2022
Q4 | $2.41M | Buy |
|
|||||
|
2022
Q3 | $2.32M | Buy |
|
|||||
|
2022
Q2 | $2.2M | Buy |
|
|||||
|
2022
Q1 | $3.19M | Buy |
|
|||||
|
2021
Q4 | $4.04M | Sell |
|
|||||
|
2021
Q3 | $9.05M | Buy |
|
|||||
|
2021
Q2 | $11.2M | Buy |
|
|||||
|
2021
Q1 | $5.94M | Sell |
|
|||||
|
2020
Q4 | $10.6M | Buy |
|
|||||
|
2020
Q3 | $2.37M | Buy |
|
|||||
|
2020
Q2 | $2.09M | Buy |
|
|||||
|
2020
Q1 | $1.13M | Buy |
|
|||||
|
2019
Q4 | $1.64M | Sell |
|
|||||
|
2019
Q3 | $1.3M | Sell |
|
|||||
|
2019
Q2 | $1.51M | Buy |
|
|||||
|
2019
Q1 | $1.44M | Sell |
|
|||||
|
2018
Q4 | $1.57M | Sell |
|
|||||
|
2018
Q3 | $2.22M | Sell |
|
|||||
|
2018
Q2 | $2.83M | Buy |
|
|||||
|
2018
Q1 | $1.88M | Buy |
|
|||||
|
2017
Q4 | $1.5M | Buy |
|
|||||
|
2017
Q3 | $1.09M | Buy |
|
|||||
|
2017
Q2 | $515K | Sell |
|
|||||
|
2017
Q1 | $1.45M | Buy |
|
|||||
|
2016
Q4 | $806K | Buy |
|
|||||
|
2016
Q3 | $31K | Sell |
|
|||||
|
2016
Q2 | $105K | Buy |
|
|||||
|
2016
Q1 | $68K | Buy |
|